The Evolut FX+ TAVR system includes an updated diamond-shaped frame, which was made four times larger than previous models to offer improved coronary access. It was also designed to provide more space for operators to guide and maneuver the catheter during procedures.

Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.

Healthcare giants Boston Scientific, Johnson & Johnson and Medtronic were all reportedly interested in acquiring Shockwave Medical in 2023. Now, new rumors suggest a deal could be finalized within weeks. 

Members of Congress are now asking the FDA to investigate a parent's claim that her 14-year-old son was treated with an experimental heart valve without proper consent. The valve eventually failed and had to be replaced. The hospital has said its heart team did nothing wrong. 

Average lengths of stay and common complications are just some of the factors care teams should consider when evaluating the costs of aortic valve replacement. 

The company already received CE mark approval for its new PFA offering and hopes it will soon be approved for sale in the United States.

Cardior Pharmaceuticals in Germany has been developing a new compound it says can “halt and partially reverse cellular pathology” in heart failure patients. 

While the American College of Cardiology's annual meeting has historically had a more clinical focus, presentations at this year's conference in Atlanta will spend much more time looking at the business side of things.